Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

As immunotherapy reshaped cancer care, geriatric oncology shifted toward personalized, geriatric assessment-guided treatment that prioritizes function, safety, and what matters most to older adults.

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journal of Clinical Oncology. The article, "The ...

Mansi didn’t grow up with abnormal periods or cramping, so a condition like endometriosis was never on her radar. However, ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

Montana Technological University has announced alumna Dr. Hannah (Dysinger) McLaughlin as the keynote speaker for its Spring 2026 commencement ceremonies on May ...

Dr. Nicoletta Colombo breaks down KEYNOTE B96 showing Keytruda plus paclitaxel, with or without Avastin, improves survival in platinum-resistant ovarian cancer. The phase 3 KEYNOTE B96 trial showed ...

Amid a health scare that nearly cost her life, Kate Mansi discovered she had been living with endometriosis for years without knowing. ‘The General Ho.

There are no widely available therapies approved for this indication ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC) today announced that, in connection with its Fidelion Diagnostics Pte. Ltd ("Fidelion") transaction, ...